Abstract

In colorectal cancer (CRC) patients, pulmonary nodules are usually considered lung metastases (LM). However, approximately 10% of LM is presented as a solitary pulmonary nodule which mimics primary lung cancer (PLC). This study aims to determine the distinguishing characteristics of the two pulmonary nodule types during postoperative surveillance of CRC patients. Between March 2009 and February 2018, 47 CRC patients with pulmonary nodules from a single institution were retrospectively analyzed. They were divided into two groups, namely CRC with second PLC (CSPLC) and CRC with LM (CRCLM), and their demographic data and clinicopathological features were analyzed. When pulmonary nodules are presented, multiple lesions and serum carcinoembryonic antigen (CEA) level>5ng/mL indicated a higher probability of CRCLM (p<0.001 and p=0.028, respectively). A CK7-/CK20+/CDX2+/TTF-1- phenotype on immunohistochemistry (IHC) stain suggested CRCLM. Other clinicopathological features showed no significant between-group differences. The median overall survival was considerably longer in the CSPLC group (not reached) than in the CRCLM group (45.41 months, p=0.064). The detection of a suspicious isolated pulmonary nodule in CRC patients warrants further workup to distinguish between SPLC and LM. Multiple lesions, serum CEA >5ng/mL when an isolated pulmonary nodule detected, and initial TNM stage IV CRC are more likely related to LM rather than SPLC. Image-guided needle biopsy and IHC stain can reduce the probability of misdiagnosis and rule out LM. CSPLC may have a favorable prognosis owing to early detection and receiving appropriate treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.